AUS
NZ
UK
CA
USA
IND
Healthcare
Knight Therapeutics Inc. (TSX: GUD) Announces Health Canada Approval for JORNAY PM® to Treat ADHD in Children
November 14, 2024 10:43 PM EST| By Team Kalkine MediaHighlights:,Health Canada approves JORNAY PM® as the first evening-dosed ADHD treatment for children aged 6-12.,The drug's unique formulation provides symptom control from morning through evening.,Knight secures exclusive distribution rights for JORN...
Is Fennec Pharmaceuticals Ready for the Spotlight at the Craig-Hallum Event?
November 13, 2024 08:15 AM EST| By Team Kalkine MediaHighlights,Fennec Pharmaceuticals to participate in a prominent healthcare investment conference.,Company aims to engage in one-on-one discussions to share business updates.,Event scheduled at Sheraton New York Times Square Hotel on November 19, 2024...
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) Subsidiary Pentavere Wins Prestigious Prix Galien USA 2024 Award
November 12, 2024 05:49 AM EST| By Team Kalkine MediaHighlights:,Pentavere’s DARWEN™ AI platform wins Prix Galien USA 2024 award in Digital Health & Medical Technology.,HEALWELL’s subsidiary recognized for making healthcare more accessible and personalized for patients.,Award marks Pentavere’s first wi...
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) Reports Higher Revenue and Growth in Q3 2024
November 12, 2024 05:46 AM EST| By Team Kalkine MediaHighlights:,HEALWELL AI achieves record revenue and gross profit, driven by AI-enabled healthcare solutions.,Company expands its footprint with key acquisitions, BioPharma and VeroSource, enhancing pharma partnerships.,HEALWELL on track to surpass $1...
Is Profound Medical’s Long-Term Outlook as Promising as It Seems?
November 11, 2024 06:34 AM EST| By Team Kalkine MediaHighlights,Profound Medical Corp. operates within the healthcare technology sector, focusing on advanced medical procedures.,Its primary offering, TULSA-PRO®, is a technology designed to improve precision in prostate disease treatment.,Latest reports...
Could Cipher Pharmaceuticals Face a Tough Financial Year Ahead?
November 11, 2024 06:18 AM EST| By Team Kalkine MediaHighlights:,Cipher Pharmaceuticals operates in the healthcare sector, focusing on specialty pharmaceuticals.,Recent forecasts suggest an adjustment in earnings expectations for Cipher Pharmaceuticals.,Leede Financial provides projected earnings estim...
Is Medexus Pharmaceuticals Facing a Challenging Earnings Forecast?
November 11, 2024 06:01 AM EST| By Team Kalkine MediaHighlights,Medexus Pharmaceuticals Inc. has seen a revised earnings forecast for fiscal year twenty twenty-six.,Leede Financial recently adjusted its projected earnings per share for Medexus, lowering it from the previous estimate.,FY twenty-twenty-s...
Why Are Investors Losing Confidence in DENTSPLY SIRONA?
November 11, 2024 03:44 AM EST| By Team Kalkine MediaHighlights:,DENTSPLY SIRONA operates in the medical instruments sector, offering dental and oral healthcare solutions.,The company's quarterly revenue increased marginally compared to the previous year, with notable earnings results.,Institutional in...
Why Did HLS Therapeutics Fall Short in Q3 2024?
November 08, 2024 02:31 PM EST| By Team Kalkine MediaHighlights,HLS Therapeutics operates in the healthcare sector, focusing on specialty pharmaceutical products.,Revenue for the third quarter showed a decrease, but net losses have narrowed compared to the previous year.,Per-share losses improved, indi...
UniDoc Health Corp. (CSE:UDOC) Ships First AI-Enhanced H3 Health Cubes to Global Healthcare Partners
November 07, 2024 06:49 AM EST| By Team Kalkine MediaHighlights:,UniDoc's H3 Health Cubes shipped to Italy, Ukraine, and rural Italy, expanding healthcare access.,Strategic partnership with Aiutamoli a Vivere Foundation and Hope Ukraine Foundation.,Deployment aims to enhance remote healthcare in unders...
Is Dentalcorp Holdings’ Debt Making It a Risky Choice?
November 06, 2024 05:56 PM EST| By Team Kalkine MediaHighlights,Dentalcorp Holdings Ltd. operates within the healthcare sector, specifically in dental services.,The company’s debt levels are a factor in evaluating its financial stability.,Understanding the role of debt can help in assessing the company...
What’s Behind Johnson & Johnson’s New Price Adjustment from Guggenheim?
November 06, 2024 05:49 PM EST| By Team Kalkine MediaHighlights,Johnson & Johnson, a leader in healthcare, offers products across pharmaceuticals, medical devices, and consumer health.,Guggenheim recently updated its target price for Johnson & Johnson, signaling a re-evaluation of the stock’s market po...
Why Is Lisata Therapeutics Betting on a Preclinical Cancer Study?
November 06, 2024 11:31 AM EST| By Team Kalkine MediaHighlights,Lisata Therapeutics collaborates with Valo Therapeutics on a new skin cancer treatment approach.,The research focuses on combining Lisata’s certepetide with Valo’s PeptiCRAd platform and a checkpoint inhibitor.,The goal is to enhance immun...
Why Is AbbVie's Trading Volume Suddenly So Low?
November 05, 2024 03:42 PM EST| By Team Kalkine MediaHighlights,AbbVie Inc. saw a slight rise in share price within Tuesday’s trading session.,Trading volume was notably lower than the average daily volume for AbbVie.,The pharmaceutical company’s stock reached a high of $201.21 and closed at $201.15.,A...
Why Is Jamieson Wellness Struggling Despite Its Financial Strength?
November 05, 2024 03:36 PM EST| By Team Kalkine MediaHighlights,Jamieson Wellness, known for health and wellness products, has seen recent fluctuations in its stock.,The company's Return on Equity (ROE) serves as a key metric to gauge its financial effectiveness.,ROE indicates the efficiency of a compa...
Is Canopy Growth’s Surprising Surge Too Good to Last?
November 05, 2024 03:20 PM EST| By Team Kalkine MediaHighlights,Canopy Growth Corporation experienced a recent share price rebound within the last month.,Despite gains, the stock remains below its value from a year ago.,With a relatively high price-to-sales (P/S) ratio of 2.5x, Canopy Growth’s valuatio...
Why Did Royal Bank of Canada Lower Adverum Biotechnologies' Price Target?
November 05, 2024 01:20 PM EST| By Team Kalkine MediaHighlights:,Adverum Biotechnologies focuses on gene therapies targeting ocular diseases.,Royal Bank of Canada adjusted Adverum's price target from a higher estimate to a revised figure.,The company maintains a sector rating that aligns with biotechno...
What Could Go Wrong with Immunic’s Latest Phase 3 MS Study?
November 05, 2024 01:15 PM EST| By Team Kalkine MediaHighlights,Immunic progresses Phase 3 Multiple Sclerosis study, following an independent committee's positive feedback.,AbbVie’s recent acquisition showcases growing interest in small-cap biotech developments.,Immunic's Jessica Breu shares insights o...
Could Grey Wolf Animal Health Corp.'s Recent Surge Be Misleading?
November 05, 2024 11:11 AM EST| By Team Kalkine MediaHighlights,Grey Wolf Animal Health,(TSXV:WOLF),has experienced substantial stock price growth in recent months.,Examining financial indicators, particularly return on equity (ROE), provides insights into the company’s financial health.,ROE can reflec...
What Makes Delivra Health’s Video Campaign a Breakthrough in Chronic Pain Advocacy?
November 04, 2024 04:08 PM EST| By Team Kalkine MediaHighlights,Delivra Health Brands launched a new video campaign focused on the daily challenges of chronic pain sufferers.,The campaign offers a humorous take on chronic pain, likening it to an unrelenting background noise.,Created in collaboration wi...
